Opening book details…
About this book
Development of a Commercial Manufacturing Route to 2-Fluoroadenine, The Key Unnatural Nucleobase of Islatravir by Cynthia M. Hong, Yingju Xu, John Y. L. Chung, Danielle M. Schultz, Mark Weisel, Richard J. Varsolona, Yong-Li Zhong, Akasha K. Purohit, Cyndi Q. He, Donald R. Gauthier, Guy R. Humphrey, Kevin M. Maloney, François Lévesque, Zhixun Wang, Aaron M.... is a book available to read on EtoBox.
- Author
- Cynthia M. Hong, Yingju Xu, John Y. L. Chung, Danielle M. Schultz, Mark Weisel, Richard J. Varsolona, Yong-Li Zhong, Akasha K. Purohit, Cyndi Q. He, Donald R. Gauthier, Guy R. Humphrey, Kevin M. Maloney, François Lévesque, Zhixun Wang, Aaron M....
- Published
- 2021
- Language
- EN
More by Cynthia M. Hong, Yingju Xu, John Y. L. Chung, Danielle M. Schultz, Mark Weisel, Richard J. Varsolona, Yong-Li Zhong, Akasha K. Purohit, Cyndi Q. He, Donald R. Gauthier, Guy R. Humphrey, Kevin M. Maloney, François Lévesque, Zhixun Wang, Aaron M....
Similar books
- Development of a Nitrene-Type Rearrangement for the Commercial Route of the JAK1 Inhibitor Abrocitinib — Christina G. Connor, Jacob C. DeForest, Phil Dietrich, Nga M. Do, Kevin M. Doyle, Shane Eisenbeis, Elizabeth Greenberg, Sarah H. Griffin, Brian P. Jones, Kris N. Jones, Michael Karmilowicz, Rajesh Kumar, Chad A. Lewis, Emma L. McInturff, J. Christopher... (2021)
- Development and Implementation of an Aluminum-Promoted Phosphorylation in the Uprifosbuvir Manufacturing Route — Zhuqing Liu, Artis Klapars, Bryon Simmons, Ana Bellomo, Alexei Kalinin, Mark Weisel, Jerry Hill & Steven M. Silverman (2021)
- Development of a Robust Manufacturing Route for Molnupiravir, an Antiviral for the Treatment of COVID-19 — Patrick S. Fier, Yingju Xu, Marc Poirier, Gilmar Brito, Michelle Zheng, Rachel Bade, Eric Sirota, Kevin Stone, Lushi Tan, Guy R. Humphrey, Darryl Chang, Jameson Bothe, Yongqian Zhang, Frank Bernardoni, Steve Castro, Michael A. Zompa, Jerry Taylor,... (2021)
- Development of a Scalable Synthetic Route to BMS-986251, Part 2: Synthesis of the Tricyclic Core and the API — Srinivas Kalidindi, Aravind S. Gangu, Sankar Kuppusamy, Shunmugaraj Sathasivam, Vijaykumar Shekarappa, Saravanan Murugan, Sivasankar Bondigela, Moorthy Kandasamy, Kishore Ghanta, Arun Vinodini, Abhishek Shrikant, Ravikumar Ramachandran, William P.... (2021)
- Development of a New Synthetic Route of the Key Intermediate of Irbesartan — Zhaohang Chen, Yuanxia Guo, Huilong Niu, Jinxin Wang, Jianming Li, Chao Li & Renzhong Qiao (2022)
- Development of Commercial Manufacturing Processes for Acalabrutinib — Paul A. Bethel, Lai Chun Chan, Katie Cooper, Gareth J. Ensor, Jerry Evarts, Rustam Garrey, J. Gair Ford, Daniel Harding, Shaun Hughes, Lucy Jackson, Michael Golden, Kirsty Millard, Andrew Phillips, Andrew Robbins, David Short, Alex Telford & David T.... (2022)